Jade Homsi is an Oncology physician affiliated with SUNY Upstate Medical University. OpenAlex indexes 151 publications with 6,744 citations (h-index 34); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
750 E. Adams St.
Syracuse, NY 13210
Telephone
315-464-8200Registry record last updated 28 Oct 2024.
Clinical trials
- Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients
Sponsor: M.D. Anderson Cancer Center
- Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20231 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20221 payment
- Novartis Pharmaceuticals CorporationProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
41%Factor Xa inhibitor41%Xarelto100%Part D<11 patientsHormonal (systemic)
31.3%l-Thyroxine31.3%Levothyroxine Sodium100%Part D<11 patientsNervous system
14.5%Gabapentinoids14.5%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development
Cancer Immunology Research
2023 - Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2022 - Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine
2022 - NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Journal of the National Comprehensive Cancer Network
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Ross, MD
SUNY Upstate Medical University
Andras Perl, MD
SUNY Upstate Medical University
Jorge Romero, MD
SUNY Upstate Medical University
Andrew Cutler, MD
SUNY Upstate Medical University
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”